Glenmark Pharmaceuticals Ltd - Share Price
GLENMARK
Glenmark Pharmaceuticals LtdFinancials
Glenmark Pharmaceuticals LtdNews & Updates
Glenmark Pharmaceuticals concludes redemption of all 2021 Notes
Jan 16,2021 11:59 AM
Glenmark Pharmaceuticals concludes redemption of all 2021 Notes
India's pharmaceutical market growth bounced to 8.5% yoy in December 2020, says Ind-Ra Jan 08,2021
Glenmark receives ANDA approvals from USFDA for three generic tablets Dec 31,2020
Glenmark Pharma rises on receiving ANDA final approval for tadalafil tablets Dec 31,2020
Glenmark receives USFDA tentative approval for Apremilast Tablets Dec 31,2020
Glenmark receives USFDA tentative approval for Gabapentin Enacarbil ER tablets Dec 31,2020
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | 596.55 | 49.65 | 143,060.35 | 724.81 | 0.67 | 3,207.24 | 106.10 |
| Divis Laboratories Ltd | 3,599.45 | 54.38 | 95,603.20 | 513.30 | 0.44 | 1,713.78 | 313.47 |
| Dr Reddys Laboratories Ltd | 5,088.90 | 34.45 | 84,595.12 | 481.00 | 0.49 | 3,333.60 | 979.38 |
| Cipla Ltd | 822.45 | 29.57 | 66,318.85 | 745.64 | 0.49 | 3,711.03 | 233.61 |
| Biocon Ltd | 451.60 | 159.05 | 54,204.00 | 95.00 | 0.00 | 560.00 | 64.73 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Glenmark Pharmaceuticals LtdSummary & Reports
Glenmark Pharmaceuticals Ltd was incorporated in November 18th, 1977. The company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets. The company has several molecules in var... More
Registered Office
B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road,Mumbai, Maharashtra,400026
Tell. : +91-22-40189999
Website : http://www.glenmarkpharma.com
Email : complianceofficer@glenmarkpharma.com
Registrar Office
Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA
Tell. : +91-40-67162222
Website : www.kfintech.com
Email : einward.ris@kfintech.com
Reports by glenmark-pharmaceuticals-ltd-share-price
Latest Release by glenmark-pharmaceuticals-ltd-share-price
Result Express
Jan 20, 2021 12:40 AM
The company’s consolidated revenue stood at Rs2,581.33cr, up 14.39% yoy and 19.2% qoq.
Shareholding Snapshot
Loading ...
| Sep - 2020 | |
|---|---|
| Promoter | - |
| Foreign | 0.00% |
| Indian | 46.63% |
| Total Promoter | 46.63% |
| Non Promoter | - |
| Institutions | 30.25% |
| Non-Institutions | 23.13% |
| Total Non-Promoter | 53.37% |
| Custodian | 0.00% |
| Total | 100% |
Corporate Action
Purpose
Board Meeting
Exp. Date
06 Nov 2020
Annc. Date
27 Oct 2020
GLENMARK PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Comp... More
Purpose
AGM
Exp. Date
29 Sep 2020
Annc. Date
31 Aug 2020
AGM 29/09/2020Further to our letter dated August 31, 2020, enclosed please find herewith the Notice ... More
Purpose
Dividend
Annc. Date
26 Jun 2020
Effective. Date
17 Sep 2020
Divi. Type
Final
Divi.(%)
250
Divi. Amt.
2.5
Glenmark Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meet... More
